Unveiling trends and clinical progress of immunotherapy for endometrial cancer: a scientometric and clinical trial landscape analysis
Our integrated scientometric and clinical trial analysis reveals a rapid evolution in EC immunotherapy research, highlighting checkpoint blockade as a central therapeutic approach. The trend toward combination regimens underscores the translational potential of immunotherapy in EC and points toward emerging directions for future research and clinical application.
Authors
- Wenhui Shan
- Zhening Wang
- Hao Wang (ORCID: https://orcid.org/0000-0001-6881-9977)
- Zhuopeng Hu (ORCID: https://orcid.org/0009-0000-2824-9957)
- Rui Guo
- Lei Yang
- Ruoyan Liu
Institutions
- Jilin University (CN)
- First Hospital of Jilin University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-02-09
- DOI
- https://doi.org/10.3389/fimmu.2026.1668903
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Jilin University
- Wu Jieping Medical Foundation
- Division of Undergraduate Education